Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Jinsheng Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1974-1920; OpenAlex author ID A5064755889. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 5

  1. Hypoxic and Acidic Tumor Microenvironment-Driven AVL9 Promotes Chemoresistance of Pancreatic Ductal Adenocarcinoma via the AVL9-IκBα-SKP1 Complex. Co-author DOI 10.1053/j.gastro.2024.10.042↗
  2. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. Co-author DOI 10.20892/j.issn.2095-3941.2023.0039↗
  3. Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC. Co-author DOI 10.3389/fcell.2022.762372↗
  4. DDX31: A Novel Functional Oncogene Promotes Migration and Proliferation of Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-520114/v1↗
  5. OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.698302↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongjie Xie · 4 shared papers, 2021–2025 · strength 0.75
  2. Yang Liu · 3 shared papers, 2021–2022 · strength 0.48
  3. Jihui Hao · 2 shared papers, 2023–2025 · strength 0.41
  4. Liangliang Wu · 2 shared papers, 2021–2022 · strength 0.36
  5. Tianxing Zhou · 1 shared paper, 2025 · strength 0.27
  6. Chuntao Gao · 2 shared papers, 2021–2023 · strength 0.26
  7. Bo Ni · 1 shared paper, 2022 · strength 0.16
  8. Shengyu Yang · 1 shared paper, 2023 · strength 0.14
  9. Danqi Fu · 1 shared paper, 2023 · strength 0.14
  10. Chongbiao Huang · 1 shared paper, 2023 · strength 0.14
  11. Xiuchao Wang · 1 shared paper, 2023 · strength 0.14
  12. Bo Tang · 1 shared paper, 2023 · strength 0.14
  13. Song Gao · 1 shared paper, 2023 · strength 0.14
  14. Tiansuo Zhao · 1 shared paper, 2023 · strength 0.14
  15. Jing Liu · 1 shared paper, 2023 · strength 0.14
  16. Ying Ma · 1 shared paper, 2023 · strength 0.14
  17. Yizhang Zhou · 1 shared paper, 2021 · strength 0.12
  18. Huizhi Sun · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.